Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986156 Alone and in Combination With Nivolumab in Advanced Solid Tumors
NCT02598960Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2015
- Primary completion
- Dec 2019
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of BMS-986156 in solid tumor, sponsored by Bristol Myers Squibb. Started Oct 2015; status: completed.
02
Drugs
BMS-986156
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02598960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02598960.